China Membrane Bioreactor market is predicted to proliferate during the forecast period 2024-2028. The market for Membrane Bioreactors in China is primarily being driven by the growing need for water treatment solutions across the country. This can be attributed to the declining freshwater resources and the increased demand from residential sector for chemical-free, pure drinking water. The market for membrane bioreactors in China is expanding as a result of rising environmental concerns regarding efficient sanitation and wastewater disposal. Nowadays, MBRs are being used for wastewater treatment in an increasing number of residential, commercial, and industrial buildings. These systems are portable, lightweight, and economical, in terms of both cost and energy use, and capable of aerating liquid to create tangential liquid flow over membranes. Additionally, the market is expanding because more companies, such as companies in the chemical, pharmaceutical, power, food and beverage, and textile sectors, are using ecologically friendly water and wastewater management techniques. The membrane bioreactor market in China is likely to expand between 2024 and 2028 as a result of other factors, such as rapid industrialization and the implementation of government regulations that encourage the use of MBRs in place of the country's present wastewater treatment facilities. Additionally,
Membrane bioreactors (MBRs) are used for the treatment of industrial and municipal wastewater. A suspended growth bioreactor (UF) is connected with a perm-selective or semi-permeable membrane technology, such as microfiltration (MF) or ultrafiltration (UF). The two most popular membrane types for MBR systems are vacuum or gravity-driven and pressure-driven systems. They keep the floating particles in place while separating the sediments from the sludge concentration. They have enhanced effluent quality, reduced carbon impact, and controlled biomass retention, and are effective against diseases including cryptosporidium and giardia when compared to conventional approaches.
The state-of-the-art MBR technology can control a wide range of water pollutants, including nitrogen, bacteria, suspended particles, pathogens, and other contaminants found in municipal and industrial waste. The moving bed biofilm reactor and traditionally activated sludge processes (ASP) are inadequate compared to MBR, for the treatment of wastewater. Reverse osmosis, microfiltration (MF), ultrafiltration (UF), and nanofiltration (NF) all employ MBR Membranes. Several polymeric materials, including polyvinylidene fluoride (PVDF), polyethylene (PE), polyethersulfone (PES), and others (RO), are used in the MBR technology. Compared to conventional systems, MBRs produce less sludge because they have smaller reactor diameters and greater sludge concentrations. In MBR, longer solid retention times (SRT) also provide improved biological treatment.
In China, for the past 20 years, membrane bioreactors (MBR) have attracted a lot of interest for the treatment and reuse of wastewater. In recent years, China's average annual growth rate has been close to 100%, compared to the global MBR market's average annual growth rate of 10.9%. More than 300 MBR plants have been put into use, successfully, for a variety of wastewater treatment processes, including municipal wastewater, bathing wastewater, restaurant wastewater, landfill leachate, hospital wastewater, petrochemical wastewater, and high-concentration industrial wastewater. These plants range in capacity from 10 to 100,000 m3/d, with over 12 MBR plants having capacities more than 10,000 m3/d. Origin Water Technology Co., Ltd. built Beijing's largest MBR plant, the Beijing Kunyu River WWPT, which can treat and reuse 100,000 m3/d of municipal wastewater. With a 30,000 m3/d capacity, Motimo Membrane Inc. constructed the largest MBR facility for the treatment of industrial wastewater in Tianjin. Petrochemical wastewater treatment is the main industrial use for MBRs, and there are currently more than 10 MBR facilities with a combined capacity of more than 5000 m3/d. The built-in MBRs in South-East China are mostly utilized for the high-strength industrial wastewater treatment, whereas MBRs in North China are mainly used for the treatment and reuse of municipal wastewater.
Download Free Sample Report
Enhance the Quality of Water
Water reclamation plants have become popular in China, while decentralized systems have been deployed in rural and individual structures. More than 80% of China's municipal water reuse volume—12.62 billion m3 in 2019—was utilized for commercial, industrial, and industrial purposes such as cooling water, processing, and boiler feed water. Toilet flushing, gardening, car washing, and firefighting are few examples of various urban applications, followed by agricultural irrigation. By the end of 2019, the total length of pipelines constructed for the use of recovered water has exceeded 15,000 km. The present rate of water reuse in China's urban areas is 19.9%, which is a relatively low figure. In 2019, more than 96.3% (63.3 billion m3) of the wastewater discharged in China's urban areas—a total of 65.7 billion m3 annually—was treated. Therefore, the demand for membrane bioreactor is expected to boost in the upcoming years.
Benefits of Membrane Bioreactor (MBR) Systems
Membrane bioreactor (MBR) systems have the capacity to process a wide range of water pollutants, including nitrogen, bacteria, pathogens, suspended particles, and other contaminants often found in municipal and industrial waste. Both the active sludge process (ASP) currently in use and the moving bed biofilm reactor (MBR), are less efficient in treating wastewater. In membrane bioreactors systems various components have been used such as hollow fibre, flat sheet & multi-tubular, microfiltration, ultrafiltration, nanofiltration, and reverse osmosis. They offer higher sludge concentrations and smaller reactor diameters than typical systems, which reduces the output of sludge. Due to the rapid urbanization and infrastructure development in developing countries, the market for membrane bioreactor (MBR) systems is predicted to climb even faster during 2024-2028. Moreover, the expansion of the China Membrane Bioreactor market's value is anticipated to be fueled by the nation's growing need for affordable and durable goods.
Recent Developments
- On 18th April
2022, through a joint venture
in China, Suez SA, which has its headquarters in Paris and specializes in water
and waste management, was awarded a 30-year build-and-operate contract for an
industrial wastewater treatment facility in Changshu. The previously extensive
strategic collaboration between SUEZ and the City of Changshu, which includes a
portfolio of water, wastewater, and waste management projects, has grown much
wider. The project supports the economy of Changshu's high standard and
ecologically responsible growth. The project also has a 15,000 m3 daily
treatment capacity and a total expenditure of about USD 41 million.
- Government Support for
Water Reuse - Due to their high
starting costs and limited consumer demand, water reuse facilities generate
comparatively low profits, emphasizing the need for government investment.
Additionally, China increased its yearly investment in fixed assets for treating
and recreating urban wastewater to USD 16.28 billion, in 2019.
- Fluence's Aspiral
manufacturing facility in Jiangsu is conveniently located to deliver Class 1A
effluent for reuse in China, even to remote areas including Taiping
Village, where a 300 m3/d Aspiral MABR-based system was delivered and
constructed in 10 days.
- On 8th April 2022,
in order to build and
install new sludge processing facilities between 2021 and 2025, the Chinese
government committed to invest around USD 8 billion.
- On 30th June
2022, the project of the
Zhangdian East Chemical Industry Park Industrial Wastewater Treatment Plant in
Zibo City, Shandong Province, has recently been improved and expanded by China
Everbright Water Deals, an environmental protection company focused on water
environment management. In 2019, the company was committed to Project Phase I,
with an investment of about USD 9.5 million.
China Membrane Bioreactor Market Challenges
Highly qualified workers are required for the operation and maintenance of the membrane bioreactor's mechanical components. The complexity of MBR means that there is a lack of qualified personnel with the required technical expertise. A certified and skilled team is required for MBR operations. Additionally, the employees should have received enough training regarding any health risks related to the handling and cleanup of chemicals. Furthermore, membrane damage could result in a significant loss of money. As a result, specialists should manage sophisticated system maintenance well.
Market Segmentation
Company Profiles
Hinada Water Treatment Tech Co. Ltd, Jiangsu Lantian Peier Membrane Co. Ltd, Hongtek Filtration Co. Ltd, Qingdao Oyang Machinery Equipment Co. Ltd
Attribute
|
Details
|
Base
Year
|
2022
|
Historical
Years
|
2018 –
2021
|
Estimated
Year
|
2023
|
Forecast
Period
|
2024 – 2028
|
Quantitative
Units
|
Revenue
in USD Billion and CAGR for 2018-2022 and 2023E-2028F
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
Segments
Covered
|
Membrane
Type
Configuration
Application
Region
|
Regional
Scope
|
East China,
South-Central China, North China, South-West China, North-East China, and
North-West China
|
Key
Companies Profiled
|
Hinada
Water Treatment Tech Co. Ltd, Jiangsu Lantian Peier Membrane Co. Ltd, Hongtek
Filtration Co. Ltd, Qingdao Oyang Machinery Equipment Co. Ltd, Bailun
Biotechnology Co. Ltd, Beijing Origin Water Membrane Technology Co. Ltd,
Bailun Biotechnology Co. Ltd. RisingSun Membrane Technology (Beijing) Co.
Ltd.
|
Customization
Scope
|
10% free
report customization with purchase. Addition or alteration to country, regional
& segment scope.
|
Pricing
and Purchase Options
|
Avail
of customized purchase options to meet your exact research needs. Explore purchase options
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/pdf format on special request)
|